Product Information

OLOPATADINE HCL 0.1% EYE DROP is a generic product labeled by SOLA Pharmaceuticals LLC, priced at $1.2677 per ML under NDC 70512052005. Its NADAC has been published 213 times since Jul 27, 2022.

FDA first approved this application on Dec 7, 2015.

OLOPATADINE HCL 0.1% EYE DROP

Olopatadine Hcl
$1.2677per ML
OTC

Strength

1 mg/mL

NDC

70512052005

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

8/19/2026

Active Ingredients

OLOPATADINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA203152

FDA Approved

12/7/2015

On Market Since

7/5/2022

Pharmacological Classes

Decreased Histamine Release
Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist
Histamine-1 Receptor Inhibitor
Mast Cell Stabilizer

Price Statistics

The NADAC for OLOPATADINE HCL 0.1% EYE DROP has been published 213 times since Jul 27, 2022, and over the history we have for it it has declined 12.8%. The table below summarizes its recorded NADAC range and movement.

Current price$1.2677 per ML
All-time high$1.7041 (Oct 12, 2022)
All-time low$1.0948 (Nov 20, 2024)
52-week high$1.3149
52-week low$1.2029
Median price$1.3243
Average price$1.3498
Largest weekly change-18.3% (Oct 19, 2022)
Weeks tracked213
Tracking sinceJul 27, 2022

Price History

1W

+2.7%

1M

+2.7%

3M

+3.9%

6M

+5.4%

1Y

-3.6%

3Y

-14.6%

5Y

N/A

All

-12.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Olopatadine Hcl market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of OLOPATADINE HCL 0.1% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE HCL 0.1% EYE DROP, manufactured by SOLA Pharmaceuticals LLC, is $1.2677 per ML (NDC 70512052005), effective Aug 19, 2026.

How has the price of OLOPATADINE HCL 0.1% EYE DROP changed over time?

Over the history we have for it, the NADAC for OLOPATADINE HCL 0.1% EYE DROP has declined 12.8%. It has been tracked across 213 weekly CMS publications since Jul 27, 2022.

What are the highest and lowest recorded NADAC prices for OLOPATADINE HCL 0.1% EYE DROP?

Since Jul 27, 2022, the NADAC for OLOPATADINE HCL 0.1% EYE DROP has ranged from a low of $1.0948 (Nov 20, 2024) to a high of $1.7041 (Oct 12, 2022), with a median of $1.3243 per ML.

Are there cheaper alternatives to OLOPATADINE HCL 0.1% EYE DROP?

No other NADAC-published product currently shares the active ingredient and strength of OLOPATADINE HCL 0.1% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures OLOPATADINE HCL 0.1% EYE DROP?

OLOPATADINE HCL 0.1% EYE DROP (NDC 70512052005) is labeled by SOLA Pharmaceuticals LLC, and CMS classifies it as a generic product.